The small bile ducts in the liver of a number of species are enmeshed by a vascular plexus, supplied largely by the hepatic artery (1) (2) (3) . This peribiliary arterial plexus has been considered by some as evidence that the bile duct epithelia might play an important and active role in the secretion of bile, possibly even to the exclusion of the parenchymal cells (4, 5) . In support of this view, it was reported that in the dog the dye sulfobromophthalein sodium (BSP) is removed more completely, and for longer periods of time, when infused into the hepatic artery than when it reaches the liver by way of the portal vein. Since the vascular pathways traversed are common for both routes of injection, except for the intercalation of the peribiliary plexus in the path of part of the arterial blood, this was the site where the extra BSP uptake was thought to take place (6) . By way of interpretation the possibility was suggested that BSP is preferentially excreted into bile when taken up by the tissues supplied by this plexus, i.e., by the smaller bile ducts.
No direct test of this hypothesis was undertaken, however. With the availability of S35-labeled BSP (7) the possibility suggested itself of using this material in conjunction with nonradioactive BSP to trace quantitatively two simultaneous BSP injections from two injection sites-portal vein and hepatic artery, for example-into bile, and thus to subject the concept of preferential biliary excretion of intra-arterially administered BSP to a critical test.
To validate the results of any such experiments requires some further analysis of the qualitative pattern of BSP excretion into bile and of the degree to which this might vary with the route by which the dye reaches the liver, as well as of the efficiency with which the dye is removed from arterial and from portal venous blood by the liver in vivo.
The present communication will deal with each of these subjects in turn, presenting validating bile secretion studies first, then the simultaneous injection experiments, and finally the extraction efficiency measurements and related studies dealing with the problem of obtaining representative hepatic vein samples.
METHODS
The experiments were carried out on female mongrel dogs, 9.5 to 15.0 Kg., which had been maintained in the laboratory on commercial canned dog food for at least six weeks. They were free of acute disease, and histopathological examination showed the livers of all animals used in these experiments to be free of significant abnormalities. Intravenous sodium pentobarbital anesthesia was employed throughout, respiratory rates being maintained between 14 and 20 per minute. Rectal temperatures were maintained above 35.5°C., if necessary, by the use of hot pads; in any one animal rectal temperature fluctuations did not exceed a range of 2.5°C.
Injections were made through polyethylene catheters, ending in 24 gage needles which were inserted into the gastrohepatic artery, 3 to 5 cm. proximal to the branchingoff of the hilar hepatic arteries, and also into the portal vein, either just cephalad of the confluence of common intestinal and mesenteric veins, or at the junction of portal and gastrosplenic veins. These catheters were inserted at laparotomy, and brought to the body surface through the incision wound which was then closed by a single line of sutures. Catheter positions were rechecked at autopsy after the completion of each experiment. The Blood samples from these catheters were withdrawn using a spring return plunger type of syringe equipped with directional ball valves (B-D Cornwall Pipetting Unit). This allowed collection of numerous 0.5 ml. samples at a rate of up to one sample per second from each catheter. The total dead space of each catheter together with its collection assembly was determined and found to be less than 1.5 ml. in every case. Mixing of samples in the system was negligible as shown by the sample concentration curves obtained on abruptly transferring the catheters from one to another solution of different composition, analyzing the catheter samples, and correcting for dead space lag.
Bile was collected into graduated centrifuge tubes from a plastic catheter inserted into the common bile duct after cholecystectomy. This catheter was -placed at the same time as the injection catheters, brought out through the laparotomy wound, and placed so that the catheter opened into the collecting tubes at a level 2 cm. above the common duct.
Sodium phenoltetrabromphthalein disulfonate (BSP) was labeled with S in the sulfonic acid groups (7 Colorimetric analyses for BSP in bile and blood plasma were carried out at 580 my. using the sample preparation and standardization methods previously described (8) . S content was determined using air dried samples plated on tissue paper covered planchets in essentially infinite layer geometry in conjunction with a thin endwindow Geiger-Muller detector. Standardization against known amounts of SUBSP added to isotope-free samples of blood or bile, and details of the counting procedure have been reported elsewhere (8) . All BSP analyses are recorded as milligrams of injected BSP equivalent to the optical density at 580 my.. or to the amount of S detected in 1 ml. of sample.
Ps-labeled chromic phosphate colloid,2 prepared according to the method of Dobson and Jones (9), was handled for injection or analysis using the precautions described by Brauer Figure 2 , the color/activity ratios for any one injection assume a constant level in the bile almost as soon as dye can be detected, and do not deviate from this value until 60 to 70 per cent of the injected S85 has been eliminated, and color due to the dye has become all but undetectable in the bile. The 358 excretion rate at this point has become very slow, less than 2 per cent of the peak value, and continues to decrease with a half-time of about one hour. Table I summarizes the results of the series of successive injections. As previously observed in continuous infusion experiments (8) , the ratio of S35BSP to BSP color in bile varies considerably from dog to dog but appears to be quite constant for any one dog regardless of route of administra- tion. On averaging separately the results after intraportal BSP administration and those after intra-arterial administration, comparison shows that route of injection does not affect the S35BSP/ BSP color ratios significantly, either in bile collected at the peak of BSP secretion, or in the accumulated total bile. The values are universally slightly higher for the accumulated bile samples because of the inclusion of some residual S35 excretion with little or no color equivalent. Absolute excretion rates are slightly higher for BSP injected into the portal vein than for that injected into the hepatic artery. Differences between the group of first injections and the group of second injections are considerably larger than those between portal vein and hepatic artery injections. The rate of bile secretion itself is faster at the time of the second BSP peak than at the corresponding point after the first injection. This correlates with slightly higher rectal temperatures (+ 0.60C. average) and respiratory rates (+ 20 per cent average). The peak BSP secretion rate is increased less than the bile flow rate. The S35BSP/BSP color ratio appears to be slightly higher-about 8 per cent average for the peak of BSP secretion, 10 per cent for the accumulated bile-for the series of second injections than for the series of first injections.
Simultaneous injections
On the basis of these results, simultaneous injection experiments to establish the relative secretion rates of identical doses of BSP delivered via hepatic artery and via portal vein must provide for determination of specific activity/color ratios for excreted BS35P for each dog and, in addition, by alternation of injection routes between dogs, allow elimination of any small effects due to the order of injections. The design adopted to meet these requirements can be represented schematically as follows: This scheme is to be replicated for successive pairs of dogs. The four individual doses of BSP making up the two injection pairs given to one dog were chemically equivalent; doses ranged from 0.30 to 0.37 mg. per Kg. for different dogs. After each first injection pair 180 minutes was allowed for completion of the dye excretion before the second injections were administered. Figure 3 shows a typical set of results, and illustrates the method of deriving the activity/color ratio for one animal. The basic graph represents rate of accumulation of S55 equivalent BSP as a function of accumulation of BSP color in the bile. In every case this plot yielded a straight line for each injection pair, with a slight upward hook near that point where BSP color excretion becomes vanishingly small while S35 excretion still continues at a slow rate (see Figure 2) . Thus, "portal vein BSP" and "hepatic artery BSP"8 are found to be excreted in constant proportion as long as BSP color excretion continues. If this proportion were known, the activity/color ratio in bile BSP could be determined directly from the slope of the curve for each injection pair; or conversely, if the color/activity ratio were known, the excretion rate ratio could be read off in the same fashion. Actually of accumulated bile BSP color on the abscissa of Figure 3 defines corresponding stages of BSP excretion for either injection pair. Since, however, the S85BSP was injected first into one and then into the other afferent vessel, every number representing accumulated BSP color in the bile corresponds to two numbers, representing S35BSP accumulated in bile after intraportal and intra-arterial S86 injection, respectively. Then, adding together the two S85BSP values, corresponding to one BSP color value, yields the total amount of S85 which is equivalent to the total color excreted, and the ratio of these two values is the S35BSP/BSP color ratio for the particular dog under study. The only assumption entailed in this calculation is that activity/color ratios must be independent of the route of injection; this point has already been established by the results shown in Table I . Thus, the slope of the summated S35BSP line (HA + PV of Figure  3 ) is a true measure of the desired activity/color ratio.
Once this number is known for a particular dog, S35BSP concentrations in bile can be converted to BSP color equivalents; by subtracting these from the total BSP color one can calculate separately the contribution to the total bile BSP color made by each of the two injections constituting either injection pair.
The results of such calculations for a series of six dogs are presented in Table II which deals with the peak of BSP excretion, and in Figure 4 which traces the course of BSP elimination from its beginning until the rate of excretion dies away. In five out of six experiments, BSP injected into the portal vein accounted for a greater portion of the dye secreted into bile than an equivalent dose placed simultaneously in the hepatic artery; in the sixth experiment, the two doses were eliminated at substantially the same rate (Table II, rates at the time of the first and second excretion peaks; as before, bile flow and BSP secretion rates are slightly higher at the time of the second peak. If the experiments are divided into two groups, according to whether the S35BSP was first injected into the hepatic artery or into the portal vein, it is found that the factor of order of injections does not modify the conclusions; the ratio of portal vein BSP to hepatic artery BSP in bile at the time of peak secretion is 8 per cent lower for the "artery first" group, slightly less than would be expected on the basis of the S35-BSP/BSP color ratio differences due to injection order found in Table I . However, even where this factor would tend to give erroneously low portal vein BSP/hepatic artery BSP ratios, the results still favor the portal vein by almost 20 per cent (Table II , bottom section, also Appendix: b).
In Figure 4 the accumulation in bile of portal vein-injected BSP is plotted as a function of hepatic artery-injected BSP accumulation. Each injection pair is represented by four points approximately equally spaced between beginning and end of bile collection. The diagonal is the locus of points representing equality between the two routes of injection; points below this line imply preferential excretion of BSP injected into the artery, points above imply preferential excretion for BSP injected into the portal vein. The results clearly fail to indicate any special role of the hepatic artery in relation to BSP secretion; on the contrary, it appears that the portal vein distributes the dye to a region whence it is secreted somewhat more effectively than if it were distributed to the liver by way of the hepatic artery.
Extraction efficiencies
To establish whether such differences exist in dye removal from the blood as might prohibit the application of the biliary excretion results to a discussion of the postulated secretory function of the peribiliary arterial plexus, an attempt was made to estimate BSP extraction efficiencies by the use of hepatic vein catheterization. However, if rapidly collected series of blood samples were obtained not only from the hepatic vein catheters, but also from vena cava or femoral artery, results typified by Figure 5A ). If the site of injection had been the portal vein, the hepatic vein catheter samples did not show high BSP concentrations until after the peripheral circulation samples, and even then hepatic vein BSP concentrations were less than peripheral ones, in a manner which would be expected if the BSP had reached the liver only by way of the peripheral circulation in the first place ( Figure 5B ). This peculiar failure of the hepatic vein catheters to "see" portal vein injected BSP could be due either to a large portacaval bypass-unlikely in the normal dog-or to a circulatory adjustment within the liver, shunting blood away from the zone sampled by an intravenous catheter. A third possibility, ascribing the effect to streamlined flow in the portal vein, was rendered highly improbable by two observations: a) if instead of the open ended needle, a sealed needle with multiple minute lateral holes were used for injection, the injection mass entered the portal vein in the form of minute jets at right angles to the line of flow, so that distribution throughout the portal blood stream should at the least have been much improved; yet the analytical results obtained by this procedure did not differ from those described for the open needle injections. b) Seven experiments were carried out in which two catheters were introduced into hepatic veins of lobes to the right and to the left of the Cantlie-Serege plane, in addition to placing sampling catheters in the vena cava just above the diaphragm, and in the femoral artery. A total of nine injections of S85 BSP, and three injections of T1824 were adminis-tered by the intraportal route in these animals. In every case the peak concentrations of dye attained in both hepatic veins were substanially lower than those found in the vena cava or femoral artery samples in the manner shown in Figure 5B ; the time of appearance of the dyes in the several sites also differed significantly, the hepatic vein sample series being delayed by about 15 seconds relative to the femoral artery samples, and by about 24 seconds relative to the vena cava sample series. Similar anomalies were not observed with hepatic artery injections. It would have to be a rather extraordinary coincidence if in every one of these experiments streamlining of portal flow would be such as to bypass two sampling sites in the two liver moieties, unless one accepts (as we do) the conclusion that the presence of a catheter in the hepatic vein tends to minimize portal flow through the tissue elements in the immediate vicinity of the catheter tip.
To obviate these sampling difficulties, IHSA was used as an internal standard so that, prior to recirculation, vena cava blood samples could be used for determination of the fraction of BSP removed from blood in one passage through the liver by the application of the analytical and computational methods described (see Methods, and Appendix: a). A typical experiment is illustrated by Figure 6 Figure 6 . The blood carrying the injected tracer mixture begins to arrive at the venous catheter six to eight seconds after the start of the injection. S85/I131 ratios remain substantially constant from this point on until blood begins to arrive which has recirculated once more through the liver. This point is marked by a sharp decrease of S35/I131 ratios which thenceforth continue to decrease in an approximately exponential fashion. The S35/I1'1 ratio during the single passage plateau period is the value from which extraction efficiency of the liver for the test substance-BSP in this caseis calculated by comparison with the corresponding ratio in the injection mass. Table IV . In three out of five dogs the hepatic arterial route of injection led to slightly higher efficiency of BSP extraction than the portal venous route; in one dog the reverse was seen; no differences were found in the fifth animal. These studies, therefore, lend some support to previous work indicating slightly greater BSP extraction from hepatic arterial blood (6) . The difference is hardly significant, however, (p > 0.1), and in its application to the biliary secretion data would serve only to reinforce the conclusion that BSP, taken up by the those regions of the liver supplied with hepatic arterial blood primarily, is not excreted in preference to portal vein-distributed BSP.
DISCUSSION
In recent years, several problems connected with the functional anatomy of the liver have been revived by workers attempting to reconcile the results of morphologic and of physiologic experimentation. One of these problems has been raised by the description of the extensive vascular and lymphatic plexus enmeshing the bile ducts (1-3) . The functional significance of this structure has given rise to a good deal of speculation concerning the possible secretory importance of the smaller bile ducts (12, 13) . Since this plexus is supplied by the hepatic artery and represents the only vascular element not traversed to an equal extent by blood from portal vein and from hepatic artery, experimental approaches have dwelt on differences in the handling of substances reaching the liver by one or the other of these vascular routes.
BSP in particular has been examined from this point of view, and differences have been described in the persistence of the ability of the liver to remove this substance from the two afferent blood streams, the hepatic arterial route presumably showing satisfactory extraction for longer periods of time than the portal route (6). Unfortunately, at the time of these experiments it had not yet been recognized that BSP is not excreted as such in the bile (14) and that after prolonged BSP infusions the proportion of BSP proper in the blood stream is actually quite small (15, 16) . Differences in BSP handling under these conditions are not readily interpretable, especially since it is clear that what ever other functions it may subserve, the peribiliary vascular plexus must be the site where considerable diffusional exchange between blood and bile constituents takes place (17) .
In testing the thesis that an excretory function is served by the peribiliary arterial-plexus, therefore, it now appeared essential to design experiments that would provide direct intercomparison of the actual rate of secretion into bile of BSP taken up as such from either the hepatic artery or the portal vein. This design, embodying bile analyses of necessity, has the further advantage that the high degree of concentration of BSP in the bile allows the use of such small doses of the dye that quite high extraction efficiencies-and consequently, quite selective distribution along the vascular pathway-could be anticipated.
In applying isotopically-labeled BSP to such experiments as a tracer for one of two simultaneous streams of dye, its conversion to a whole family of optically indistinguishable dyes of varying color to radioactivity ratios poses a special problem (8) . It was demonstrated in the present series of experiments that the route of injection does not measurably affect this ratio, so that no bias is introduced into the analyses from this source. A possible small difference between successive injections in the same animal was recognized but could be eliminated by proper alternation of injection routes.
On this basis the key experiment of the present series is that represented by Table II and Figure 4 , comparing the rates of secretion into bile of equal doses of BSP simultaneously reaching the liver of the same animal by way of either portal vein or hepatic artery. The experimental results do not under any circumstances admit of the interpretation that BSP injected into the hepatic artery is preferentially excreted. There is an indication, on the contrary, that the portal venous route affords a small but quite consistent advantage-BSP injected by this route being eliminated about 15 to 20 per cent faster at the time of peak BSP elimination.
The significance of this observation for the assessment of the functional role of the hepatic artery depends upon the additional information presented in Table IV concerning hepatic extraction efficiencies for BSP. The fact that these are either route independent, or that the hepatic arterial flow is somewhat more completely cleared of BSP-this in line with previous observations (6) -justified the conclusion that the vascular region supplied by the hepatic artery is not peculiarly active in transferring BSP from blood to bile. This would appear to remove any present justification from the postulate that the structures supplied by the peribiliary plexus (notably the smaller bile ducts) are endowed with any specific functional importance with regard to bile secretion. The present evidence does not, of course, bear upon a possible role of the structures in this region in the resorption of various components from bile in progress through the biliary tree.
Knowledge of the first passage extraction efficiencies for BSP allows an estimate of the actual distribution of BSP among vascular regions, provided one can estimate the relative blood flow rates through the two major vessels. A reasonable (and conservative) relation applicable to the present conditions would appear to be somewhere between 1/3 and 1/5 for the ratio hepatic arterial/ portal venous flow (18) (19) (20) (21) (22) ; together with an initial extraction efficiency of 50 per cent this would lead to eventual distribution of BSP between the two vascular regions of 85/15 for the case of intraportal, and 35/65 for the case of intra-arterial injection. Thus, distribution differences would appear large enough to reveal any real differences in excretory activity.
There is not, at present, any explanation for the faster excretion into bile of portal vein-carried BSP suggested by Table II and Figure 4 . One would be inclined to seek for explanations either in differences in mean oxygen tensions obtaining in regions receiving blood from the one or the other source, or in peculiarities of the sinusoidal circulation. An attempt was made to test this alternative by carrying out experiments analogous to the ones here reported under total oxygen tensions of 3.4 atmospheres resulting in "arterialization" of all circulating blood. The results suggested that oxygenation does not affect the excretory relations depicted in Figure 4 ; interpretation of these experiments, however, is rendered less than satisfactory by simultaneously occurring changes in respiratory movements and in rectal temperatures, both of which may have a bearing on bile flow and bile secretion.
Finally, attention may be called briefly to the results epitomized by Figure 5 and Table IV confirming in dogs under the experimental conditions of the present series the existence of a catheterization artifact as reported by Sapirstein and Reininger (23) , and lending support to their general interpretation of the nature of this phenomenon. The present authors feel that a special reflex vasoconstriction is not required for interpretation of these observations but that the plasticity of blood flow distribution in the sinusoidal bed alone suffices to account for the deflection of portal flow away from a catheterized region. If borne out, this interpretation would assign to the hepatic arterial circulation a new role as an emergency supply to regions of the hepatic parenchyma, the circulation of which has been mildly compromised. Such a role could become of prime importance in the early stages of the development of liver injury by preventing the establishment of the vicious circle of liver disease envisioned by Himsworth (24) .
As applied to hepatic vein sampling, the present results suggest that even if one encounters a catheterization artifact, in the normal liver at least, this is not important in BSP or CrPO4 studies unless one specifically desires to discriminate between hepatic artery and portal vein as injection routes. Thus, if the test substances are injected into the peripheral circulation of such animals in such a way that they reach portal vein and hepatic artery in the same concentrations, the lack of difference between the efficiency of BSP or CrPO4 removal from either blood stream implies that hepatic catheterization ought to yield meaningful results.
In the present case, of course, these assumptions could not be made a priori but, on the contrary, their verification was the object of the experiments. The use of an internal standard which allows sampling vena cava blood above the liver, in lieu of hepatic vein blood, was shown to obviate these difficulties and appears to be satisfactory for wider application whenever plasma protein flux across the hepatic tree is not excessive. It might be mentioned in passing that the limitations of this procedure are such that clear discrimination of first passage and recirculation phases becomes difficult unless samples are drawn close to the point of admixture of hepatic vein and vena cava blood streams. 
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for an injection pair involving S31 BSP injection into the hepatic artery. In these equations A and V, A' and V' are artery and vein-derived BSP after first and second injections; S and C, and S' and C' are corresponding S35BSP
and BSP color concentrations after first and second injections; and S and C are the cumulative S31BSP and BSP color amounts (see Figure 3 ) from which the color/activity ratio is calculated. If the order of injections were as represented by the sequence of equations here, one would be dealing with a "portal vein first" experiment in the sense of Table II . The sequence effect illustrated at the bottom of Table I would lead to the prediction that S' would be too large (relative to S) by about 10 per cent, and S would therefore be too large by about -2-or 5 per cent. Examination of the equations for -and -, shows A A' that in this case both calculated ratios should be smaller than they would be in the absence of a sequence effect, and would deviate from the "correct" value by about the same amount (in the present example, provided A is not too different from V, and S from C the error would amount 2'7 to about 10 per cent). By the same reasoning in "artery first" experiments the calculated values for V and VI would be increased as a result of the injection sequence effect. As seen in Table II , the observed direction of the discrepancies between "portal vein first" and "artery first" experiments is as predicted, although the observed spread of mean values is somewhat smaller than would follow from these calculations.
